These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 22699526)
1. The diagnostic and prognostic value of ¹⁸F-FDG PET/CT in the initial assessment of high-grade bone and soft tissue sarcoma. A retrospective study of 89 patients. Fuglø HM; Jørgensen SM; Loft A; Hovgaard D; Petersen MM Eur J Nucl Med Mol Imaging; 2012 Sep; 39(9):1416-24. PubMed ID: 22699526 [TBL] [Abstract][Full Text] [Related]
2. Semi-Quantitative Calculations of Primary Tumor Metabolic Activity Using F-18 FDG PET/CT as a Predictor of Survival in 92 Patients With High-Grade Bone or Soft Tissue Sarcoma. Andersen KF; Fuglo HM; Rasmussen SH; Petersen MM; Loft A Medicine (Baltimore); 2015 Jul; 94(28):e1142. PubMed ID: 26181552 [TBL] [Abstract][Full Text] [Related]
3. Volume-Based F-18 FDG PET/CT Imaging Markers Provide Supplemental Prognostic Information to Histologic Grading in Patients With High-Grade Bone or Soft Tissue Sarcoma. Andersen KF; Fuglo HM; Rasmussen SH; Petersen MM; Loft A Medicine (Baltimore); 2015 Dec; 94(51):e2319. PubMed ID: 26705220 [TBL] [Abstract][Full Text] [Related]
4. FDG PET/CT imaging in primary osseous and soft tissue sarcomas: a retrospective review of 212 cases. Charest M; Hickeson M; Lisbona R; Novales-Diaz JA; Derbekyan V; Turcotte RE Eur J Nucl Med Mol Imaging; 2009 Dec; 36(12):1944-51. PubMed ID: 19593561 [TBL] [Abstract][Full Text] [Related]
5. Differentiation of soft tissue and bone sarcomas from benign lesions utilizing Chen B; Feng H; Xie J; Li C; Zhang Y; Wang S BMC Med Imaging; 2020 Jul; 20(1):85. PubMed ID: 32711449 [TBL] [Abstract][Full Text] [Related]
6. Dual-time point 18FDG-PET/CT imaging may be useful in assessing local recurrent disease in high grade bone and soft tissue sarcoma. Dancheva Z; Bochev P; Chaushev B; Yordanova T; Klisarova A Nucl Med Rev Cent East Eur; 2016; 19(1):22-7. PubMed ID: 26841376 [TBL] [Abstract][Full Text] [Related]
7. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer. Qiu ZL; Xue YL; Song HJ; Luo QY Nucl Med Commun; 2012 Dec; 33(12):1232-42. PubMed ID: 23111353 [TBL] [Abstract][Full Text] [Related]
9. The impact of Elmanzalawy A; Vali R; Chavhan GB; Gupta AA; Omarkhail Y; Amirabadi A; Shammas A Pediatr Radiol; 2020 Feb; 50(2):252-260. PubMed ID: 31628508 [TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of (18)F-FDG PET at diagnosis in patients with soft tissue sarcoma and bone sarcoma; systematic review and meta-analysis. Kubo T; Furuta T; Johan MP; Ochi M Eur J Cancer; 2016 May; 58():104-11. PubMed ID: 26990930 [TBL] [Abstract][Full Text] [Related]
11. Utility of positron emission tomography/computed tomography (PET/CT) imaging in the evaluation of sarcomas: A systematic review. Lim HJ; Johnny Ong CA; Tan JW; Ching Teo MC Crit Rev Oncol Hematol; 2019 Nov; 143():1-13. PubMed ID: 31449981 [TBL] [Abstract][Full Text] [Related]
12. Necrosis on FDG PET/CT correlates with prognosis and mortality in sarcomas. Rakheja R; Makis W; Tulbah R; Skamene S; Holcroft C; Nahal A; Turcotte R; Hickeson M AJR Am J Roentgenol; 2013 Jul; 201(1):170-7. PubMed ID: 23789672 [TBL] [Abstract][Full Text] [Related]
13. (18)F-FDG PET as a single imaging modality in pediatric neuroblastoma: comparison with abdomen CT and bone scintigraphy. Choi YJ; Hwang HS; Kim HJ; Jeong YH; Cho A; Lee JH; Yun M; Lee JD; Kang WJ Ann Nucl Med; 2014 May; 28(4):304-13. PubMed ID: 24481823 [TBL] [Abstract][Full Text] [Related]
14. The role of 18F-FDG PET/CT in soft tissue sarcoma. Sambri A; Bianchi G; Longhi A; Righi A; Donati DM; Nanni C; Fanti S; Errani C Nucl Med Commun; 2019 Jun; 40(6):626-631. PubMed ID: 30908341 [TBL] [Abstract][Full Text] [Related]
15. Predictive value of (18)F-FDG PET/CT in restaging patients affected by ovarian carcinoma: a multicentre study. Caobelli F; Alongi P; Evangelista L; Picchio M; Saladini G; Rensi M; Geatti O; Castello A; Laghai I; Popescu CE; Dolci C; Crivellaro C; Seghezzi S; Kirienko M; De Biasi V; Cocciolillo F; Quartuccio N; Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):404-13. PubMed ID: 26381775 [TBL] [Abstract][Full Text] [Related]
17. Comparison of FDG PET/CT and MRI in lymph node staging of endometrial cancer. Kim HJ; Cho A; Yun M; Kim YT; Kang WJ Ann Nucl Med; 2016 Feb; 30(2):104-13. PubMed ID: 26546334 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic accuracy of dual-time-point 18F-FDG PET/CT for the detection of axillary lymph node metastases in breast cancer patients. Hahn S; Hecktor J; Grabellus F; Hartung V; Pöppel T; Kimmig R; Forsting M; Antoch G; Heusner TA Acta Radiol; 2012 Jun; 53(5):518-23. PubMed ID: 22547387 [TBL] [Abstract][Full Text] [Related]
19. Is methylene diphosphonate bone scan necessary for initial staging of Ewing sarcoma if 18F-FDG PET/CT is performed? Ulaner GA; Magnan H; Healey JH; Weber WA; Meyers PA AJR Am J Roentgenol; 2014 Apr; 202(4):859-67. PubMed ID: 24660717 [TBL] [Abstract][Full Text] [Related]
20. Prediction of Pathologic Grade and Prognosis in Mucoepidermoid Carcinoma of the Lung Using ¹⁸F-FDG PET/CT. Park B; Kim HK; Choi YS; Kim J; Zo JI; Choi JY; Shim YM Korean J Radiol; 2015; 16(4):929-35. PubMed ID: 26175595 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]